Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/06/1998CA2278678A1 Cancer immunotherapy with semi-allogeneic cells
08/06/1998CA2278675A1 Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
08/06/1998CA2278638A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998CA2278595A1 Secreted proteins and polynucleotides encoding them
08/06/1998CA2278189A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
08/06/1998CA2251036A1 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998CA2222981A1 Promoter of the human endoglin gene and its use
08/05/1998EP0856583A2 Protein rab3 GEP
08/05/1998EP0856582A2 Inhibitor protein of transcription factors and its DNA
08/05/1998EP0856581A2 Stably transfected cell lines expressing GABA-A receptors
08/05/1998EP0856580A1 Recombinant conglutinin and process for producing the same
08/05/1998EP0856579A1 An antisense oligonucleotide preparation method
08/05/1998EP0856520A1 Method of preparing a monoclonal antibody, monoclonal antibody, a pharmaceutical composition and a diagnostic reagent
08/05/1998EP0856519A2 Antibacterial insect protein
08/05/1998EP0856317A1 A stabilized mixture comprising fibrinogen
08/05/1998EP0856314A1 Immunosuppressant
08/05/1998EP0856157A1 Tumour-specific p450 protein
08/05/1998EP0856062A2 Herpesvirus vectors and their uses
08/05/1998EP0856061A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells
08/05/1998EP0856058A1 Cell-cycle checkpoint genes
08/05/1998EP0856056A1 Fibronectic binding protein b compounds
08/05/1998EP0856055A1 Streptavidin mutants
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998EP0856052A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998EP0856050A1 Transforming growth factor alpha hi
08/05/1998EP0856009A1 Cd6 ligand
08/05/1998EP0856007A1 Cyclopeptide derivatives
08/05/1998EP0856005A1 The aiolos gene
08/05/1998EP0855918A1 Chicken interleukin-15 and uses thereof
08/05/1998EP0855917A1 Stable pharmaceutical forms of administration containing parathormone
08/05/1998EP0855916A1 Pharmaceutical composition containing an activin or inhibin stimulator
08/05/1998EP0855915A2 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0855910A1 Conjugates useful in the treatment of benign prostatic hyperplasia
08/05/1998EP0855906A1 Insoluble drug delivery
08/05/1998EP0831819A4 Method for inhibiting neoplastic disease in mammals
08/05/1998EP0766694B1 Peptide derivatives with metallopeptidase inhibitory activity
08/05/1998EP0747477A4 Strain of trichoderma harzieanum rifai, process for obtaining l-lysine-alpha-oxidase as an inhibitor of viral and bacterial activity, immunomodulator and skin healing agent
08/05/1998EP0722452A4 Nf-at polypeptides and polynucleotides
08/05/1998EP0690872B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/05/1998EP0627926B1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/05/1998EP0606391B1 Inhibition of vascular narrowing using anti-padgem antibodies
08/05/1998EP0584286B1 Use of platelet derived growth factor in the preparation of a medicament for the treatment of gastrointestinal ulcers
08/05/1998CN1189851A Human Beta 2 integrin alpha subunit
08/05/1998CN1189839A Compsns. and methods for detecting and treating acquired immunodeficiency syndrome
08/05/1998CN1189837A Peptide and method of obtaining it
08/05/1998CN1189836A DNA sequence and encoded mammary-specific breast cancer protein
08/05/1998CN1189777A Tissue adhesive using synthetic cross-linking agent
08/05/1998CN1189502A Method for producing antithrombin-III, method for purifying it, and preparation containing it
08/05/1998CN1189378A Application and prodn. method of HDL preparation
08/05/1998CA2221687A1 Tumor necrosis related receptor, tr5
08/04/1998US5790421 Computer apparatus for expressing a three dimensional structure of a G-CSF molecule or analogs thereof
08/04/1998US5789654 Transgenic animals deficient in endogenous β3 -adrenergic receptor and uses thereof
08/04/1998US5789601 Method of inactivation of viral and bacterial blood contaminants
08/04/1998US5789573 Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
08/04/1998US5789565 Serine threonine kinase receptor, ALK-7
08/04/1998US5789559 DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789551 Human leukocyte interferon Hu-IFN-α001
08/04/1998US5789550 TRAF inhibitors
08/04/1998US5789549 Genetic engineering; translation
08/04/1998US5789547 Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
08/04/1998US5789543 Vertebrate embryonic pattern-inducing proteins and uses related thereto
08/04/1998US5789542 Amphipathic peptides
08/04/1998US5789541 Enzyme inhibitors, farnesyl or geranyl groups, controlling neoplastic cell growth, antitumor, anticarcinogenic agents
08/04/1998US5789540 Anticoagulant peptides
08/04/1998US5789539 Chemokine-like proteins and methods of use
08/04/1998US5789537 Method for preparing streptogramins
08/04/1998US5789531 Peptide-based inhibitors of HIV replication
08/04/1998US5789447 Nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/04/1998US5789441 Leukotriene B4 as an antiviral and anti-neoplastic agent
08/04/1998US5789426 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
08/04/1998US5789414 Protect dna from damage
08/04/1998US5789411 Improvements to rapid opioid detoxification
08/04/1998US5789403 Substituted thiazolo 3,2-a!azepine derivatives
08/04/1998US5789390 Genetic enginering and vectors
08/04/1998US5789389 Genetic suppressor elements useful for sensitizing cancer cells to the cytotoxic effects of chemotherapeutic drugs
08/04/1998US5789384 Administering (cyclic) isoleucine-tryptophan dipeptide, tripeptide, or its polymer to treat immunodeficiency
08/04/1998US5789383 Peptides for treatment of herpes and varicella-zoster
08/04/1998US5789382 Retro-peptide fibroblast growth factor which blocks FGF receptor
08/04/1998US5789381 Pulmonary surfactant proteins and related polypeptides
08/04/1998US5789380 Agents for inhibiting accumulation of visceral fat
08/04/1998US5789379 Intestinal tissue growth factors
08/04/1998US5789377 Blocking tumor necrosis factor
08/04/1998US5789376 Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
08/04/1998US5789248 CAPL-specific oligonucleotides and method of inhibiting metastatic cancer
08/04/1998US5789245 Genetic engineering
08/04/1998US5789244 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
08/04/1998US5789237 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
08/04/1998US5789223 Human galactokinase gene
08/04/1998US5789218 DNA encoding valyl tRNA synthetase from Staphylococcus aureus
08/04/1998US5789217 Protection against bacterial infections
08/04/1998US5789208 Polyclonal antibody libraries
08/04/1998US5789203 Protein complexes having factor VIII:C activity and production thereof
08/04/1998US5789202 DNA encoding a novel penicillin binding protein from streptococcus pneumoniae
08/04/1998US5789201 Genes coding for bcl-y a bcl-2 homologue
08/04/1998US5789200 Polypeptides and dna(rna) codes by genetic engineering for diagnosis and treatment of cancer, prostate, breast, lung or epithelial tumors
08/04/1998US5789198 Human leptin receptor-related protein
08/04/1998US5789197 Microsomal triglyceride transfer protein